🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
The purpose of this booster vaccination study is to evaluate the persistenc...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00135564
Treatments Being Tested
This multicentre, parallel group, block randomised clinical trial aims to i...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2015-08
Trial ID
NCT02482636
In the UK, infants currently receive a 5-in-1 vaccine (Pediacel) at 2, 3 an...
Status
Completed
Location
St George's Vaccien Institute
Start Date
2013-07
Trial ID
NCT01896596
The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Status
Completed
Location
University of Oxford, Oxford Vaccine Group
Start Date
2014-06-20
Trial ID
NCT02002156
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
This protocol posting deals with objectives \& outcome measures of an exten...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-14
Trial ID
NCT00891176
This study will evaluate the immunogenicity of the co-administration of dif...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09-30
Trial ID
NCT00352963
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335